IFP Advisors
HRTX icon

IFP Advisors’s Heron Therapeutics HRTX Stock Holding History

IFP Advisors’s Portfolio HRTX Stock Details HRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$24 Sell
75
-45
-38% -$17 ﹤0.01% 5125
2026
Q2 		$51 Sell
120
-216
-64% -$173 ﹤0.01% 5020
2026
Q1 		$269 Sell
336
-25
-7% -$29 ﹤0.01% 4561
2025
Q4 		$469 Sell
361
-155
-30% -$191 ﹤0.01% 4298
2025
Q3 		$650 Buy
516
+482
+1,418% +$764 ﹤0.01% 4097
2025
Q2 		$70 Buy
+34
New +$69 ﹤0.01% 4776
2025
Q1 		– Sell
-35
Closed -$54 – 4465
2024
Q4 		$54 Buy
+35
New +$57 ﹤0.01% 4236
2023
Q4 		– Sell
-271
Closed -$279 – 3188
2023
Q3 		$279 Buy
+271
New +$386 ﹤0.01% 3164
2021
Q2 		– Sell
-200
Closed -$3.18K – 3133
2021
Q1 		$3K Buy
200
+158
+376% +$2.82K ﹤0.01% 2564
2020
Q4 		$1K Buy
+42
New +$730 ﹤0.01% 2763
2019
Q1 		– Sell
-14
Closed – – 2812
2018
Q4 		$0 Sell
14
-225
-94% -$6.19K ﹤0.01% 3685
2018
Q3 		$8K Buy
239
+25
+12% +$931 ﹤0.01% 2971
2018
Q2 		$8K Buy
+214
New +$6.81K ﹤0.01% 3031
2017
Q1 		– Sell
-1
Closed – – 4051
2016
Q4 		$0 Hold
1
– – ﹤0.01% 4045
2016
Q3 		$0 Sell
1
-11
-92% -$204 ﹤0.01% 3953
2016
Q2 		$0 Buy
+12
New +$234 ﹤0.01% 3923
2016
Q1 		– Sell
-11
Closed – – 2831
2015
Q4 		$0 Buy
+11
New +$294 ﹤0.01% 3755

Other funds holding HRTX

BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Tejara Capital
Tejara Capital London, United Kingdom $205M AUM 0.53% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $73.4B AUM 32.8% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
Panagora Asset Management
Panagora Asset Management Boston, Massachusetts $33.2B AUM 43.67% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $463B AUM

IFP Advisors's HRTX Position: Q3 2026 in Review

IFP Advisors reduced its Heron Therapeutics (HRTX) stake by 38% in Q3 2026, selling an estimated $17 and leaving 75 shares worth $24. The position accounts for ﹤0.01% of the portfolio, ranked #5125.

IFP Advisors first reported a position in HRTX in Q4 2015 and has held it in 17 quarters since. The position peaked at $8K in Q3 2018. 121 funds tracked by Wall St. Rank hold HRTX as of Q3 2026.

  • IFP Advisors held 75 shares of Heron Therapeutics worth $24 as of Q3 2026.
  • IFP Advisors sold 45 Heron Therapeutics shares in Q3 2026, an estimated $17.
  • Heron Therapeutics made up ﹤0.01% of IFP Advisors's portfolio in Q3 2026, its #5125 holding.
  • IFP Advisors first reported a position in Heron Therapeutics in Q4 2015 and has held it in 17 quarters since.
  • IFP Advisors's Heron Therapeutics position peaked at $8K in Q3 2018.
  • 121 funds tracked by Wall St. Rank held Heron Therapeutics as of Q3 2026.

Based on IFP Advisors's 13F filing for Q3 2026, filed 16 Oct 2026.